Northwestern Medicine® scientists have found the molecular pathway that can prevent the death of immature ovarian eggs due to chemotherapy, potentially preserving fertility and endocrine function.
Mary McGrae McDermott, MD, professor of medicine, has been selected to receive the designation Master of the Society of Vascular Medicine (SVM), the highest award bestowed by the organization. She was presented with the award at the recent national SVM meeting.
Meant to transform cancer research, a group of 11 schools have formed a collaboration to leverage the scientific and clinical expertise of individual institutions.
In a surprising new finding, a Northwestern Medicine® study has found a common molecular vulnerability in autism and fetal alcohol spectrum disorder. Both disorders have symptoms of social impairment and originate during brain development in utero.
Research published in The Journal of Neuroscience identifies a new key factor in the generation of febrile seizures, leading to a new therapeutic target for humans.
Karl Bilimoria, MD, assistant professor in surgical oncology and medical social sciences, is one of four scientists receiving a $150,000 grant from the National Comprehensive Cancer Network®.
Nearly one-third of the University’s publications in this prestigious journal last year featured medical school faculty as the principal investigator.
A phase 1 clinical trial for the first treatment to reset the immune system of multiple sclerosis patients showed that the therapy was safe and dramatically reduced patients’ immune systems’ reactivity to myelin by 50 to 75 percent, according to new Northwestern Medicine® research.
Susan Quaggin, MD, chief of the Division of Nephrology, has been given the Alfred Newton Richards Award from the International Society of Nephrology for basic science research in the field. The honor was presented June 2 in Hong Kong during the World Congress of Nephrology, the leading biennial educational event in international nephrology.
The third annual event co-sponsored by neurology and the Les Turner ALS Foundation brought together scientists, students, and guests to learn more about the molecular link between two often disconnected fields of study.